Innate lymphoid cells support regulatory T cells in the intestine through interleukin-2.


Journal

Nature
ISSN: 1476-4687
Titre abrégé: Nature
Pays: England
ID NLM: 0410462

Informations de publication

Date de publication:
04 2019
Historique:
received: 29 06 2018
accepted: 28 02 2019
pubmed: 5 4 2019
medline: 27 11 2019
entrez: 5 4 2019
Statut: ppublish

Résumé

Interleukin (IL)-2 is a pleiotropic cytokine that is necessary to prevent chronic inflammation in the gastrointestinal tract

Identifiants

pubmed: 30944470
doi: 10.1038/s41586-019-1082-x
pii: 10.1038/s41586-019-1082-x
pmc: PMC6481643
mid: NIHMS1522936
doi:

Substances chimiques

Antigens 0
Interleukin-1beta 0
Interleukin-2 0
Myd88 protein, mouse 0
Myeloid Differentiation Factor 88 0
Nod2 Signaling Adaptor Protein 0
Nod2 protein, mouse 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

405-409

Subventions

Organisme : NIDDK NIH HHS
ID : R21 DK110262
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI145989
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI123368
Pays : United States
Organisme : NIH HHS
ID : DP5 OD012116
Pays : United States
Organisme : NIDDK NIH HHS
ID : R01 DK126871
Pays : United States
Organisme : NIAID NIH HHS
ID : F32 AI124517
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI143842
Pays : United States
Organisme : NIAID NIH HHS
ID : U01 AI095608
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Boyman, O. & Sprent, J. The role of interleukin-2 during homeostasis and activation of the immune system. Nat. Rev. Immunol. 12, 180–190 (2012).
doi: 10.1038/nri3156
Malek, T. R. The biology of interleukin-2. Annu. Rev. Immunol. 26, 453–479 (2008).
doi: 10.1146/annurev.immunol.26.021607.090357
Sadlack, B. et al. Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75, 253–261 (1993).
doi: 10.1016/0092-8674(93)80067-O
Josefowicz, S. Z., Lu, L. F. & Rudensky, A. Y. Regulatory T cells: mechanisms of differentiation and function. Annu. Rev. Immunol. 30, 531–564 (2012).
doi: 10.1146/annurev.immunol.25.022106.141623
Belkaid, Y. & Tarbell, K. Regulatory T cells in the control of host–microorganism interactions. Annu. Rev. Immunol. 27, 551–589 (2009).
doi: 10.1146/annurev.immunol.021908.132723
Izcue, A., Coombes, J. L. & Powrie, F. Regulatory lymphocytes and intestinal inflammation. Annu. Rev. Immunol. 27, 313–338 (2009).
doi: 10.1146/annurev.immunol.021908.132657
Tanoue, T., Atarashi, K. & Honda, K. Development and maintenance of intestinal regulatory T cells. Nat. Rev. Immunol. 16, 295–309 (2016).
doi: 10.1038/nri.2016.36
Zhou, L. & Sonnenberg, G. F. Essential immunologic orchestrators of intestinal homeostasis. Sci. Immunol. 3, eaao1605 (2018).
doi: 10.1126/sciimmunol.aao1605
Klatzmann, D. & Abbas, A. K. The promise of low-dose interleukin-2 therapy for autoimmune and inflammatory diseases. Nat. Rev. Immunol. 15, 283–294 (2015).
doi: 10.1038/nri3823
Popmihajlov, Z., Xu, D., Morgan, H., Milligan, Z. & Smith, K. A. Conditional IL-2 gene deletion: consequences for T cell proliferation. Front. Immunol. 3, 102 (2012).
doi: 10.3389/fimmu.2012.00102
Artis, D. & Spits, H. The biology of innate lymphoid cells. Nature 517, 293–301 (2015).
doi: 10.1038/nature14189
Spits, H. et al. Innate lymphoid cells—a proposal for uniform nomenclature. Nat. Rev. Immunol. 13, 145–149 (2013).
doi: 10.1038/nri3365
Sonnenberg, G. F. & Artis, D. Innate lymphoid cells in the initiation, regulation and resolution of inflammation. Nat. Med. 21, 698–708 (2015).
doi: 10.1038/nm.3892
Atarashi, K. et al. Th17 cell induction by adhesion of microbes to intestinal epithelial cells. Cell 163, 367–380 (2015).
doi: 10.1016/j.cell.2015.08.058
Gaboriau-Routhiau, V. et al. The key role of segmented filamentous bacteria in the coordinated maturation of gut helper T cell responses. Immunity 31, 677–689 (2009).
doi: 10.1016/j.immuni.2009.08.020
Sano, T. et al. An IL-23R/IL-22 circuit regulates epithelial serum amyloid A to promote local effector Th17 responses. Cell 163, 381–393 (2015).
doi: 10.1016/j.cell.2015.12.047
Philpott, D. J., Sorbara, M. T., Robertson, S. J., Croitoru, K. & Girardin, S. E. NOD proteins: regulators of inflammation in health and disease. Nat. Rev. Immunol. 14, 9–23 (2014).
doi: 10.1038/nri3565
Narni-Mancinelli, E. et al. Fate mapping analysis of lymphoid cells expressing the NKp46 cell surface receptor. Proc. Natl Acad. Sci. USA 108, 18324–18329 (2011).
doi: 10.1073/pnas.1112064108
Robson, M. J. et al. Generation and characterization of mice expressing a conditional allele of the interleukin-1 receptor type 1. PLoS ONE 11, e0150068 (2016).
doi: 10.1371/journal.pone.0150068
Mortha, A. et al. Microbiota-dependent crosstalk between macrophages and ILC3 promotes intestinal homeostasis. Science 343, 1249288 (2014).
doi: 10.1126/science.1249288
Hepworth, M. R. et al. Innate lymphoid cells regulate CD4
doi: 10.1038/nature12240
Hepworth, M. R. et al. Group 3 innate lymphoid cells mediate intestinal selection of commensal bacteria-specific CD4
doi: 10.1126/science.aaa4812
Kim, K. S. et al. Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine. Science 351, 858–863 (2016).
doi: 10.1126/science.aac5560
Hadis, U. et al. Intestinal tolerance requires gut homing and expansion of FoxP3
doi: 10.1016/j.immuni.2011.01.016
Pabst, O. & Mowat, A. M. Oral tolerance to food protein. Mucosal Immunol. 5, 232–239 (2012).
doi: 10.1038/mi.2012.4
Boschetti, G. et al. Therapy with anti-TNFα antibody enhances number and function of Foxp3
doi: 10.1002/ibd.21308
Bernink, J. H. et al. Human type 1 innate lymphoid cells accumulate in inflamed mucosal tissues. Nat. Immunol. 14, 221–229 (2013).
doi: 10.1038/ni.2534
Johansson, M. E. & Hansson, G. C. Immunological aspects of intestinal mucus and mucins. Nat. Rev. Immunol. 16, 639–649 (2016).
doi: 10.1038/nri.2016.88
Mowat, A. M. & Agace, W. W. Regional specialization within the intestinal immune system. Nat. Rev. Immunol. 14, 667–685 (2014).
doi: 10.1038/nri3738
Maloy, K. J. & Powrie, F. Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature 474, 298–306 (2011).
doi: 10.1038/nature10208

Auteurs

Lei Zhou (L)

Division of Gastroenterology, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA.
Department of Microbiology and Immunology, Weill Cornell Medicine, Cornell University, New York, NY, USA.
Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, Cornell University, New York, NY, USA.

Coco Chu (C)

Division of Gastroenterology, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA.
Department of Microbiology and Immunology, Weill Cornell Medicine, Cornell University, New York, NY, USA.
Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, Cornell University, New York, NY, USA.

Fei Teng (F)

Division of Gastroenterology, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA.
Department of Microbiology and Immunology, Weill Cornell Medicine, Cornell University, New York, NY, USA.
Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, Cornell University, New York, NY, USA.

Nicholas J Bessman (NJ)

Division of Gastroenterology, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA.
Department of Microbiology and Immunology, Weill Cornell Medicine, Cornell University, New York, NY, USA.
Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, Cornell University, New York, NY, USA.

Jeremy Goc (J)

Division of Gastroenterology, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA.
Department of Microbiology and Immunology, Weill Cornell Medicine, Cornell University, New York, NY, USA.
Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, Cornell University, New York, NY, USA.

Endi K Santosa (EK)

Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, Cornell University, New York, NY, USA.

Gregory G Putzel (GG)

Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, Cornell University, New York, NY, USA.

Hiroki Kabata (H)

Division of Gastroenterology, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA.
Department of Microbiology and Immunology, Weill Cornell Medicine, Cornell University, New York, NY, USA.
Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, Cornell University, New York, NY, USA.

Judith R Kelsen (JR)

Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, and the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Robert N Baldassano (RN)

Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, and the Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.

Manish A Shah (MA)

Weill Cornell Medicine, New York Presbyterian Hospital, New York, NY, USA.

Robbyn E Sockolow (RE)

Department of Pediatrics, Division of Gastroenterology and Nutrition, Weill Cornell Medicine, Cornell University, New York, NY, USA.

Eric Vivier (E)

APHM, CIML, Hôpital de la Timone, Immunologie, Marseille Immunopole, Aix Marseille University, Marseille, France.
Innate Pharma Research Laboratories, Innate Pharma, Marseille, France.

Gérard Eberl (G)

Microenvironment and Immunity Unit, Institut Pasteur, Paris, France.

Kendall A Smith (KA)

Division of Immunology, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA.

Gregory F Sonnenberg (GF)

Division of Gastroenterology, Joan and Sanford I. Weill Department of Medicine, Weill Cornell Medicine, Cornell University, New York, NY, USA. gfsonnenberg@med.cornell.edu.
Department of Microbiology and Immunology, Weill Cornell Medicine, Cornell University, New York, NY, USA. gfsonnenberg@med.cornell.edu.
Jill Roberts Institute for Research in Inflammatory Bowel Disease, Weill Cornell Medicine, Cornell University, New York, NY, USA. gfsonnenberg@med.cornell.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH